Columbia University Medical Center
NewYork-Presbyterian Hospital The University Hospital of Columbia and Cornell

Studies for Cognitive Impairment

Treatment of Psychosis and Agitation in Alzheimer’s Disease

This research study, funded by the NIH, involves a 12-week double-blind treatment trial in which outpatients with Alzheimer’s disease (age 55-95 years) who have agitation/aggression or psychosis (hallucinations or delusions) will receive either low-dose lithium or placebo. Patients are allowed to receive other specific psychiatric medications if needed during the study, and will be closely monitored by physicians who specialize in memory disorders. Patients will receive open treatment with lithium, if clinically indicated, after completing the 12-week double blind trial.

For more information, please contact Kristina D’Antonio at (646) 774-8668.

Donepezil Treatment Study for Cognitively Impaired Elderly

We are conducting a research study, funded by the NIH, for people ages 55+ with memory complaints. Patients with amnestic Mild Cognitive Impairment or probable Alzheimer's disease are eligible. The study includes medical evaluation and follow-up monitoring by physicians who specialize in memory disorders, cognitive testing, olfactory testing, and treatment with medication. Treatment is provided for eligible individuals at no cost for a year.

For more information, please contact Jennifer Ferrar (646) 774-7204 or Daniel Valmas (646) 774-7202.

 

chronos interior